Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 20,000 shares at $118.87 ($2.4M) on 2021-11-18, disclosed to the SEC on 2021-11-19.
Open-market sale of $2.4M EW by CVP, Critical Care. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.98 | 2,390 | $280K | 11.9% |
| 2 | $116.98 | 2,390 | $280K | 11.9% |
| 3 | $117.88 | 6,357 | $749K | 31.8% |
| 4 | $117.88 | 6,357 | $749K | 31.8% |
| 5 | $118.87 | 1,253 | $149K | 6.3% |
| 6 | $118.87 | 1,253 |
| $149K |
| 6.3% |
| Total | $117.79 avg | 20,000 | $2.4M | 100% |
| Filing → |
| EW | SELL | 2023-09-08 | $380K | — | Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |